(28213908) An RCT comparing lacosamide and fosphenytoin found similar efficacy among patients with nonconvulsive seizures (using the 400 mg IV dose of lacosamide)
Its completely normal and is an indicator that the bacteriostatic agent is present
The formulation, potency, and safety profile match branded alternatives, with lower cost and no insurance barriers
However, for research purposes, you need to dissolve this powder into a liquid solution
Starting doses of 250 mcg daily are typical, with assessment at 4 weeks before deciding whether to continue, increase, or adjust the protocol
In fact, thats the part Al-Aly says opens the door to a new SUD approach that targets the underlying biology shared by all of them, rather than managing each substance individually